Are you an academic researcher looking for cutting-edge drug discovery tools? Join our Academic Access Program!

Selectively targeting proteins for removal from the cell, instead of inhibiting protein activity, is a newer modality for potential therapy. The protein is targeted for degradation using the cell’s natural ubiquitin proteasome system (UPS). Compounds such as molecular glues and proteolysis targeting chimeras (PROTACs) initiate this process by linking the target protein to an E3 ligase. The cell’s UPS does the rest.

Promega offers a comprehensive selection of CRISPR-edited cell line pools and clones to facilitate studying popular protein degradation targets, using sensitive bioluminescence technology.

View Available Cell LinesDownload List (PDF)

Need help with assay development, compound screening or profiling? Learn more about our targeted protein degradation services.

View TPD Services

Join us for the "Cracking the Undruggable Code" virtual symposium on October 22–24, 2024!
Learn more »

Key Questions To Consider When Developing Protein Degraders

Promega offers a portfolio of cell-based assays for use in development of effective protein degraders. These products are used to answer the following key questions:

key stages in protac mediation

Need help with Assay Development, Screening or Profiling?

Learn more about our targeted protein degradation services.